104 related articles for article (PubMed ID: 14513235)
1. [Vacuum sealing of extensive wound healing disorders after kidney transplantation].
Hodzic J; Adams J; Staehler G; Wiesel M
Urologe A; 2003 Aug; 42(8):1097-100. PubMed ID: 14513235
[TBL] [Abstract][Full Text] [Related]
2. Impact of mycophenolate mofetil on wound complications and lymphoceles after kidney transplantation.
Lopau K; Syamken K; Rubenwolf P; Riedmiller H; Wanner C
Kidney Blood Press Res; 2010; 33(1):52-9. PubMed ID: 20197687
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for wound healing complications in sirolimus-treated renal transplant recipients.
Grim SA; Slover CM; Sankary H; Oberholzer J; Benedetti E; Clark NM
Transplant Proc; 2006 Dec; 38(10):3520-3. PubMed ID: 17175320
[TBL] [Abstract][Full Text] [Related]
4. The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients.
Flechner SM; Zhou L; Derweesh I; Mastroianni B; Savas K; Goldfarb D; Modlin CS; Krishnamurthi V; Novick A
Transplantation; 2003 Dec; 76(12):1729-34. PubMed ID: 14688524
[TBL] [Abstract][Full Text] [Related]
5. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S;
Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205
[TBL] [Abstract][Full Text] [Related]
7. A systematic approach to minimizing wound problems for de novo sirolimus-treated kidney transplant recipients.
Tiong HY; Flechner SM; Zhou L; Wee A; Mastroianni B; Savas K; Goldfarb D; Derweesh I; Modlin C
Transplantation; 2009 Jan; 87(2):296-302. PubMed ID: 19155988
[TBL] [Abstract][Full Text] [Related]
8. Improved long-term allograft function in pediatric renal transplantation with mycophenolate mofetil.
Ferraris JR; Ghezzi LF; Vallejo G; Piantanida JJ; Araujo JL; Sojo ET
Pediatr Transplant; 2005 Apr; 9(2):178-82. PubMed ID: 15787789
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor I improves aspects of mycophenolate mofetil-impaired anastomotic healing in an experimental model.
Inglin RA; Baumann G; Wagner OJ; Candinas D; Egger B
Br J Surg; 2008 Jun; 95(6):793-8. PubMed ID: 18418858
[TBL] [Abstract][Full Text] [Related]
10. Maintenance immunosuppression with mycophenolate mofetil and corticosteroids in pediatric kidney transplantation: temporary benefit but not without risk.
Cransberg K; Cornelissen M; Lilien M; Van Hoeck K; Davin JC; Nauta J
Transplantation; 2007 Apr; 83(8):1041-7. PubMed ID: 17452893
[TBL] [Abstract][Full Text] [Related]
11. [Mycophenolate mofetil].
Abramowicz D; Broeders N; Wissing M; Sternon J
Rev Med Brux; 1998 Jun; 19(3):139-43. PubMed ID: 9697397
[TBL] [Abstract][Full Text] [Related]
12. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
[TBL] [Abstract][Full Text] [Related]
13. The use of vacuum-assisted closure in the treatment of post-transplant wound infections: a case series.
Routledge T; Saeb-Parsy K; Murphy F; Ritchie AJ
J Heart Lung Transplant; 2005 Sep; 24(9):1444. PubMed ID: 16143271
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil in cadaveric renal transplantation. US Renal Transplant Mycophenolate Mofetil Study Group.
Am J Kidney Dis; 1999 Aug; 34(2):296-303. PubMed ID: 10430977
[TBL] [Abstract][Full Text] [Related]
15. Does mycophenolate mofetil increase the incidence of cytomegalovirus disease compared with azathioprine after cadaveric kidney transplantation?
Basic-Jukic N; Kes P; Bubic-Filipi LJ; Puretic Z; Brunetta B; Pasini J
Transplant Proc; 2005 Mar; 37(2):850-1. PubMed ID: 15848553
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of traumatic soft tissue defect by vacuum sealing].
Yao YZ; Huang XK; Ma XL
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Nov; 16(6):388-90. PubMed ID: 12508428
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of low-dose mycophenolate mofetil therapy for Taiwanese renal transplantation patients receiving primary cyclosporine immunosuppression.
Tsai MK; Hu RH; Lee CJ; Lee PH
J Formos Med Assoc; 2002 Sep; 101(9):616-21. PubMed ID: 12645188
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174
[TBL] [Abstract][Full Text] [Related]
20. Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation.
Guethoff S; Meiser BM; Groetzner J; Eifert S; Grinninger C; Ueberfuhr P; Reichart B; Hagl C; Kaczmarek I
Transplantation; 2013 Feb; 95(4):629-34. PubMed ID: 23423270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
